KDR and neoplasm: The main mechanism of action for apatinib is preventing VEGFR‐2 downstream signaling pathways and blocking the migration and proliferation of vascular endothelial cells, reducing tumor microvessel density, and inhibiting tumor angiogenesis.10, 11, 12, 13